Medicrea

OverviewSuggest Edit

MEDICREA is a fully-dedicated spinal implant company focused on introducing reliable and innovative technologies to revolutionize the global operating room marketplace. With over 18 years of experience, MEDICREA provides a full range of patented products that are conceived, developed and manufactured to advance patient outcomes and support the work of medical professionals.
TypePublic
HQNeyron, FR
Websitemedicrea.com
Employee Ratings3.1

Latest Updates

Employees (est.) (Nov 2020)175(-2%)
Revenue (FY, 2019)€32.7 M(+2%)
Share Price (Nov 2020)€6.9
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Medicrea

Fabrice Kilfiger

Fabrice Kilfiger

Chief Financial Officer
Richard Kienzle

Richard Kienzle

Director
Joe Walland

Joe Walland

CEO of MEDICREA USA
David Ryan

David Ryan

Chief Operating Officer
Pierre Olivier

Pierre Olivier

Director
Thomas Mosnier

Thomas Mosnier

Chief Scientific Officer
Show more

Medicrea Office Locations

Medicrea has an office in Neyron
Neyron, FR (HQ)
14 Porte du Grand Lyon
Show all (1)

Medicrea Financials and Metrics

Medicrea Revenue

Embed Graph
View revenue for all periods
Medicrea's revenue was reported to be €32.72 m in FY, 2019
EUR

Revenue (H1, 2020)

13.2m

Gross profit (H1, 2020)

10.5m

Gross profit margin (H1, 2020), %

79.4%

Net income (H1, 2020)

(6.3m)

EBITDA (H1, 2020)

1.4m

EBIT (H1, 2020)

(2.8m)

Market capitalization (18-Nov-2020)

146.3m

Closing stock price (18-Nov-2020)

6.9

Cash (30-Jun-2020)

13.2m

EV

193.1m
Medicrea's current market capitalization is €146.3 m.
Annual
EURFY, 2018FY, 2019

Revenue

32.3m32.7m

Cost of goods sold

(3.2m)(7.3m)

Gross profit

29.0m25.5m

Gross profit Margin, %

90%78%
Half Year
EURH1, 2019H1, 2020

Revenue

16.1m13.2m

Cost of goods sold

(3.1m)(2.7m)

Gross profit

12.9m10.5m

Gross profit Margin, %

81%79%
Annual
EURFY, 2018FY, 2019

Cash

10.8m3.8m

Accounts Receivable

5.4m4.9m

Prepaid Expenses

2.3m2.4m

Inventories

9.7m9.3m
Half Year
EURH1, 2019H1, 2020

Cash

3.2m13.2m

Accounts Receivable

6.2m4.3m

Prepaid Expenses

2.1m1.6m

Inventories

9.8m8.8m
Annual
EURFY, 2018FY, 2019

Net Income

(11.8m)(15.5m)

Depreciation and Amortization

6.0m

Inventories

14.0k750.0k

Accounts Payable

130.0k(237.0k)
Half Year
EURH1, 2019H1, 2020

Net Income

(7.0m)(6.3m)

Depreciation and Amortization

3.9m4.3m

Inventories

(234.0k)(133.0k)

Accounts Payable

692.0k(1.2m)
EURFY, 2018

Debt/Equity

2.5 x

Debt/Assets

0.6 x

Financial Leverage

4.1 x
Show all financial metrics

Medicrea Revenue Breakdown

Embed Graph

Medicrea revenue breakdown by business segment: 100.0% from CONCEPTION, DÉVELOPPEMENT, FABRICATION ET COMMERCIALISATION D’IMPLANTS ORTHOPÉDIQUES DESTINÉS À LA CHIRURGIE DE LA COLONNE VERTÉBRALE

Medicrea revenue breakdown by geographic segment: 19.9% from FRANCE, 11.2% from RESTE DU MONDE, 54.7% from ETATS-UNIS, 11.4% from BELGIUM and 2.8% from Other

Medicrea Cybersecurity Score

Cybersecurity ratingPremium dataset

B

89/100

SecurityScorecard logo

Medicrea Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Medicrea Online and Social Media Presence

Embed Graph

Medicrea News and Updates

Medtronic Completes Acquisition of Medicrea

DUBLIN, Nov. 16, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it has completed its friendly tender offer for France-based Medicrea International (Euronext Growth Paris: FR0004178572 – ALMED Medicrea; OTCQX Best Market –...

Medtronic to acquire the French implant tech company Medicrea

Medtronic says the acquisition means it will be able to offer AI-driven surgical planning, robotic assisted surgery and personalized spinal implants.

Medtronic to Acquire Medicrea

Medtronic Will Become the First Company to Offer an Integrated Solution Including Artificial Intelligence-Driven Surgical Planning, Personalized Spinal Implants and Robotic Assisted Surgery

Medicrea Group wins FDA clearance for AI-based spine surgery tech

The company’s new health IT in part uses analytics and machine learning to assist spine surgeons and help create personalized implants.

Medicrea Blogs

Medicrea raises €8.5 million through a private placement

Download Press release >>>

Medicrea lève 8,5 millions d’euros par placement privé

Téléchargez le communiqué de presse >>>

Medicrea Reports 2019 Annual Sales

Download Press release >>>

Medicrea annonce son chiffre d’affaires annuel 2019

Téléchargez le communiqué de presse >>>
Show more

Medicrea Frequently Asked Questions

  • Who are Medicrea key executives?

    Medicrea's key executives are Fabrice Kilfiger, Richard Kienzle and Joe Walland.

  • How many employees does Medicrea have?

    Medicrea has 175 employees.

  • What is Medicrea revenue?

    Latest Medicrea annual revenue is €32.7 m.

  • What is Medicrea revenue per employee?

    Latest Medicrea revenue per employee is €187 k.

  • Who are Medicrea competitors?

    Competitors of Medicrea include Vapotherm, Electromed and Aeroflow Healthcare.

  • Where is Medicrea headquarters?

    Medicrea headquarters is located at 14 Porte du Grand Lyon, Neyron.

  • Where are Medicrea offices?

    Medicrea has an office in Neyron.

  • How many offices does Medicrea have?

    Medicrea has 1 office.